Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 626

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries

Pereira, Marta, Lunet, Nuno, Azevedo, Ana, Barros, Henrique·2009·Journal of Hypertension
DOI 10.1097/hjh.0b013e3283282f65
Open this paper in CoChat — free account

Abstract

Objective To systematically review quantitative differences in the prevalence, awareness, treatment and control of hypertension between developed and developing countries over the past 6 years. Methods We searched Medline [prevalence AND awareness AND treatment AND control AND (hypertension OR high blood pressure)] for population-based surveys. Prevalence, awareness, treatment and control of hypertension were compared between men and women, and between developing and developed countries, adjusting for age. The proportions of awareness, treatment and control were defined relative to the total number of hypertensive patients. Results We identified 248 articles, of which 204 did not fulfill inclusion criteria. The remaining articles reported data from 35 countries. Among men, the mean prevalence, awareness, treatment and control of hypertension were 32.2, 40.6, 29.2 and 9.8%, respectively, in developing countries and 40.8, 49.2, 29.1 and 10.8%, respectively, in developed countries. Among women, the mean prevalence, awareness, treatment and control of hypertension were 30.5, 52.7, 40.5, and 16.2%, respectively, in developing countries and 33.0, 61.7, 40.6 and 17.3%, respectively, in developed countries. After adjusting for age, the prevalence of hypertension among men was lower in developing than in developed countries (difference, S6.5%; 95% confidence interval, S11.3 to S1.8%). Conclusion There were no significant differences in mean prevalence, awareness, treatment and control of hypertension between developed and developing countries, except for a higher prevalence among men in developed countries. The prevalence, awareness, treatment and control of hypertension in developing countries are coming closer to those in developed countries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3283282f65

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 77

  1. Chobanian, 2003, The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 · DOI · Paper page
  2. Klag, 1996, Blood pressure and end-stage renal disease in men, N Engl J Med, 334, 13, 10.1056/NEJM199601043340103 · DOI · Paper page
  3. Jager, 1999, Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study, Arterioscler Thromb Vasc Biol, 19, 617, 10.1161/01.ATV.19.3.617 · DOI · Paper page
  4. Stokes, 1989, Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up, Hypertension, 13, I13, 10.1161/01.HYP.13.5_Suppl.I13 · DOI · Paper page
  5. Rodgers, 2004, Distribution of major health risks: findings from the Global Burden of Disease study, PLoS Med, 1, e27, 10.1371/journal.pmed.0010027 · DOI · Paper page
  6. Ezzati, 2002, Selected major risk factors and global and regional burden of disease, Lancet, 360, 1347, 10.1016/S0140-6736(02)11403-6 · DOI · Paper page
  7. Manton, 1988, The global impact of noncommunicable diseases: estimates and projections, World Health Stat Q, 41, 255
  8. Toto, 2005, Treatment of hypertension in chronic kidney disease, Semin Nephrol, 25, 435, 10.1016/j.semnephrol.2005.05.016 · DOI
  9. Yusuf, 1989, Changes in hypertension treatment and in congestive heart failure mortality in the United States, Hypertension, 13, I74, 10.1161/01.HYP.13.5_Suppl.I74 · DOI
  10. Moser, 1996, Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials, J Am Coll Cardiol, 27, 1214, 10.1016/0735-1097(95)00606-0 · DOI · Paper page
  11. 1996, Report of a WHO Expert Committee., World Health Organ Tech Rep Ser, 862, 1
  12. Kearney, 2004, Worldwide prevalence of hypertension: a systematic review, J Hypertens, 22, 11, 10.1097/00004872-200401000-00003 · DOI · Paper page
  13. Lawes, 2006, Blood pressure and the global burden of disease. Part 1: estimates of blood pressure levels, J Hypertens, 24, 413, 10.1097/01.hjh.0000199801.72563.6f · DOI · Paper page
  14. Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet, 365, 217, 10.1016/S0140-6736(05)17741-1 · DOI · Paper page
  15. Joop, 2005, Demography of the immigrants in the Netherlands., Central Bureau of Statistics, 96-, 117
  16. Antikainen, 2006, Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project, Eur J Cardiovasc Prev Rehabil, 13, 13
  17. 2005, Racial/ethnic disparities in prevalence, treatment, and control of hypertension-United States, 1999-2002., MMWR Morb Mortal Wkly Rep, 54, 7
  18. Dickson, 2006, The impact of lifestyle behavior on hypertension awareness, treatment, and control in a southeastern population, Am J Med Sci, 332, 211, 10.1097/00000441-200610000-00010 · doi:10.1097/00000441-200610000-00010
  19. Howard, 2006, Racial and geographic differences in awareness, treatment, and control of hypertension: the Reasons for Geographic and Racial Differences in Stroke study, Stroke, 37, 1171, 10.1161/01.STR.0000217222.09978.ce · DOI · Paper page
  20. Hennis, 2002, Hypertension prevalence, control and survivorship in an Afro-Caribbean population, J Hypertens, 20, 2363, 10.1097/00004872-200212000-00014 · doi:10.1097/00004872-200212000-00014
  21. Inamo, 2005, Arterial hypertension in the French Caribbean regions: gender related differences, Arch Mal Coeur Vaiss, 98, 845
  22. Fasce, 2007, Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile, J Hypertens, 25, 1807, 10.1097/HJH.0b013e328244e481 · DOI
  23. Atallah, 2007, Reducing the burden of arterial hypertension: what can be expected from an improved access to healthcare? Results from a study in 2420 unemployed subjects in the Caribbean, J Hum Hypertens, 21, 316, 10.1038/sj.jhh.1002150 · DOI
  24. Ordunez-Garcia, 2006, Success in control of hypertension in a low-resource setting: the Cuban experience, J Hypertens, 24, 845, 10.1097/01.hjh.0000222753.67572.28 · DOI
  25. Agyemang, 2006, Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa, J Hum Hypertens, 20, 67, 10.1038/sj.jhh.1001923 · DOI · Paper page
  26. Ben Romdhane, 2005, Hypertension prevalence, awareness, treatment and control: results from a community based survey, Tunis Med, 83, 41
  27. Danon-Hersch, 2007, Decreasing association between body mass index and blood pressure over time, Epidemiology, 18, 493, 10.1097/EDE.0b013e318063eebf · DOI
  28. Wang, 2004, Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992–1998, Hypertens Res, 27, 703, 10.1291/hypres.27.703 · doi:10.1291/hypres.27.703
  29. Li, 2003, Awareness, treatment and control of hypertension in patients attending hospital clinics in China, J Hypertens, 21, 1191, 10.1097/00004872-200306000-00020 · DOI
  30. Gu, 2002, Prevalence, awareness, treatment, and control of hypertension in china, Hypertension, 40, 920, 10.1161/01.HYP.0000040263.94619.D5 · DOI · Paper page
  31. Asai, 2001, Prevalence, awareness, treatment, and control of hypertension in Japanese rural communities, Nippon Koshu Eisei Zasshi, 48, 827
  32. Pan, 2001, Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993–1996, J Hum Hypertens, 15, 793, 10.1038/sj.jhh.1001268 · doi:10.1038/sj.jhh.1001268
  33. Jo, 2001, Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study, J Hypertens, 19, 1523, 10.1097/00004872-200109000-00002 · DOI · Paper page
  34. Choi, 2006, Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001, J Hypertens, 24, 1515, 10.1097/01.hjh.0000239286.02389.0f · DOI · Paper page
  35. Howteerakul, 2006, Health risk behaviours, awareness, treatment and control of hypertension among rural community people in Thailand, Asia Pac J Public Health, 18, 3, 10.1177/10105395060180010201 · DOI
  36. Altun, 2005, Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003, J Hypertens, 23, 1817, 10.1097/01.hjh.0000176789.89505.59 · DOI · Paper page
  37. Hazarika, 2004, Hypertension in the native rural population of Assam, Natl Med J India, 17, 300
  38. Lim, 2004, Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996, Singapore Med J, 45, 20
  39. Zachariah, 2003, Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala, Indian Heart J, 55, 245
  40. Deepa, 2003, Is the ‘rule of halves’ in hypertension still valid? Evidence from the Chennai Urban Population Study, J Assoc Physicians India, 51, 153
  41. Tugay Aytekin, 2002, Distribution of blood pressures in Gemlik District, north-west Turkey, Health Soc Care Community, 10, 394, 10.1046/j.1365-2524.2002.00379.x · DOI
  42. Mohan, 2007, Prevalence, awareness and control of hypertension in Chennai: the Chennai Urban Rural Epidemiology Study (CURES-52), J Assoc Physicians India, 55, 326
  43. Chaturvedi, 2007, Hypertension in Delhi: prevalence, awareness, treatment and control, Trop Doct, 37, 142, 10.1258/004947507781524593 · DOI
  44. Efstratopoulos, 2006, Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study, Am J Hypertens, 19, 53, 10.1016/j.amjhyper.2005.07.011 · DOI
  45. Macedo, 2005, Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study, J Hypertens, 23, 1661, 10.1097/01.hjh.0000179908.51187.de · DOI · Paper page
  46. Psaltopoulou, 2004, Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study, Int J Epidemiol, 33, 1345, 10.1093/ije/dyh249 · DOI
  47. Sarafidis, 2004, Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study, J Hum Hypertens, 18, 623, 10.1038/sj.jhh.1001724 · DOI
  48. Panagiotakos, 2003, Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet – the Attica study, J Hypertens, 21, 1483, 10.1097/00004872-200308000-00011 · DOI
  49. Menotti, 2001, Impact of the Gubbio population study on community control of blood pressure and hypertension. Gubbio Study Research Group, J Hypertens, 19, 843, 10.1097/00004872-200105000-00002 · DOI
  50. Perez-Fernandez, 2007, Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases, J Hum Hypertens, 21, 366, 10.1038/sj.jhh.1002158 · DOI
  51. Primatesta, 2001, Improved hypertension management and control: results from the health survey for England 1998, Hypertension, 38, 827, 10.1161/hyp.38.4.827 · DOI · Paper page
  52. Primatesta, 2006, Improvement in hypertension management in England: results from the Health Survey for England 2003, J Hypertens, 24, 1187, 10.1097/01.hjh.0000226210.95936.bc · DOI
  53. Meisinger, 2006, Regional disparities of hypertension prevalence and management within Germany, J Hypertens, 24, 293, 10.1097/01.hjh.0000200508.10324.8e · DOI · Paper page
  54. Lang, 2001, Prevalence and therapeutic control of hypertension in 30,000 subjects in the workplace, Hypertension, 38, 449, 10.1161/01.HYP.38.3.449 · doi:10.1161/01.hyp.38.3.449
  55. Agyemang, 2005, Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study, J Hypertens, 23, 1971, 10.1097/01.hjh.0000186835.63996.d4 · DOI
  56. Scheltens, 2007, Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension, J Hum Hypertens, 21, 99, 10.1038/sj.jhh.1002123 · DOI
  57. Agyemang, 2006, Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor Survey, J Hypertens, 24, 2169, 10.1097/01.hjh.0000249693.73618.c9 · DOI
  58. Zdrojewski, 2004, Arterial hypertension in Poland in 2002, J Hum Hypertens, 18, 557, 10.1038/sj.jhh.1001739 · DOI
  59. Cifkova, 2004, Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study, J Hum Hypertens, 18, 571, 10.1038/sj.jhh.1001686 · DOI
  60. Kunes, 2006, Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view, Clin Sci (Lond), 111, 295, 10.1042/CS20050271 · DOI
  61. Marteau, 2005, Genetic determinants of blood pressure regulation, J Hypertens, 23, 2127, 10.1097/01.hjh.0000186024.12364.2e · DOI
  62. Birkett, 1997, The effect of alternative criteria for hypertension on estimates of prevalence and control, J Hypertens, 15, 237, 10.1097/00004872-199715030-00004 · DOI
  63. Cavelaars, 2004, Reproducibility of intra-arterial ambulatory blood pressure: effects of physical activity and posture, J Hypertens, 22, 1105, 10.1097/00004872-200406000-00010 · DOI
  64. Okojie, 1994, Gender inequalities of health in the Third World, Soc Sci Med, 39, 1237, 10.1016/0277-9536(94)90356-5 · DOI
  65. Craft, 1997, Women's health is a global issue, BMJ, 315, 1154, 10.1136/bmj.315.7116.1154 · DOI
  66. Koopmans, 2007, Gender and healthcare utilization: the role of mental distress and help-seeking propensity, Soc Sci Med, 64, 1216, 10.1016/j.socscimed.2006.11.018 · DOI · Paper page
  67. Green, 1999, Gender, psychosocial factors and the use of medical services: a longitudinal analysis, Soc Sci Med, 48, 1363, 10.1016/S0277-9536(98)00440-7 · DOI · Paper page
  68. Baghdadi, 2005, Gender and medicines: an international public health perspective, J Womens Health (Larchmt), 14, 82, 10.1089/jwh.2005.14.82 · doi:10.1089/jwh.2005.14.82
  69. Stockwell, 1994, The determinants of hypertension awareness, treatment, and control in an insured population, Am J Public Health, 84, 1768, 10.2105/AJPH.84.11.1768 · DOI
  70. Alexander, 1999, Evaluating hypertension control in a managed care setting, Arch Intern Med, 159, 2673, 10.1001/archinte.159.22.2673 · DOI
  71. Knight, 2001, Predictors of uncontrolled hypertension in ambulatory patients, Hypertension, 38, 809, 10.1161/hy0901.091681 · DOI · Paper page
  72. Hicks, 2004, Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity, Hypertension, 44, 429, 10.1161/01.HYP.0000141439.34834.84 · DOI
  73. Majernick, 2004, Correlates of hypertension control in a primary care setting, Am J Hypertens, 17, 915, 10.1016/j.amjhyper.2004.05.016 · DOI
  74. Fuentes, 2000, Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998, J Hypertens, 18, 521, 10.1097/00004872-200018050-00003 · DOI
  75. Neal, 2000, Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration, Lancet, 356, 1955, 10.1016/S0140-6736(00)03307-9 · DOI · Paper page
  76. Mensah, 2008, Epidemiology of stroke and high blood pressure in Africa, Heart, 94, 697, 10.1136/hrt.2007.127753 · DOI · Paper page
  77. Evans, 2001, Trends in coronary risk factors in the WHO MONICA project, Int J Epidemiol, 30, S35, 10.1093/ije/30.suppl_1.S35 · DOI · Paper page

Cited by

See all 626

Metadata

Authors
Pereira, M., Lunet, N., Azevedo, A., & Barros, H.
Venue
Journal of Hypertension
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2009-05
Volume
27
Issue
5
Pages
963-975
ISSN
0263-6352 (ISSN-L)
DOI
10.1097/hjh.0b013e3283282f65
OpenAlex
W1984450750
Cited by
626
References
5
FWCI
24.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. https://app.cochat.ai/papers/10.1097/hjh.0b013e3283282f65
The paper
Pereira, M., Lunet, N., Azevedo, A., & Barros, H. (2009). Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3283282f65

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.